Company: AIP
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001667011-25-000029
Chunk: 254

Company: Arteris, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 254
---
 to be determined by customers at a future period. The Company expects to recognize $48.2 million of this balance over the next 12 months and the remainder thereafter. FSA commitments amounted to $6.0 million and $2.3 million as of June 30, 2025 and December 31, 2024, respectively. The Company has elected to exclude the potential future royalty receipts from these amounts.Costs of Obtaining a Contract with a CustomerIncremental costs of obtaining a contract with a customer consist primarily of direct sales commissions incurred upon execution of the contract. These costs are required to be capitalized under ASC 340-40, Other Assets and Deferred Costs—Contracts With Customers, and amortized over the license term. As direct sales commissions paid for term extensions are commensurate with the amounts paid for initial contracts, the deferred incremental costs for initial contracts and for term extensions are recognized over the respective contract terms. Total capitalized direct commission costs were as follows (in thousands):As ofJune 30,2025December 31,2024Short-term commission capitalized in prepaid expenses and other current assets$2,267 $2,311 Long-term commission capitalized in other assets1,902 1,789 Total$4,169 $4,100 Amortization of capitalized sales commissions was $0.9 million for both the three months ended June 30, 2025 and 2024, and $1.7 million and $1.8 million for the six months ended June 30, 2025 and 2024, respectively, and are included in sales and marketing expense in the unaudited condensed consolidated statements of operations.

4.    NET LOSS PER SHARE

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):Three Months EndedJune 30,Six Months EndedJune 30,2025202420252024Numerator:Net loss$(9,130)$(8,344)$(17,251)$(17,747)Denominator:Weighted-average shares outstanding, basic and diluted41,819,427 38,476,934 41,338,907 38,092,996 Net loss per share, basic and diluted$(0.22)$(0.22)$(0.42)$(0.47)Since the Company was in a loss position for all periods presented, the diluted earnings per share was equal to